About CoheroHealth
CoheroHealth is a company based in New York (United States) founded in 2013 was acquired by Aptar in November 2020. CoheroHealth has raised $17.15 million across 4 funding rounds from investors including Aptar, StartUp Health and Samsung NEXT. CoheroHealth offers products and services including BreatheSmart App, MSpirometer, and HeroTracker Sensors. CoheroHealth operates in a competitive market with competitors including Wellth, Cureatr, Phil, Capsa Healthcare and Spencer Health Solutions, among others.
- Headquarter New York, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CoheroHealth
CoheroHealth offers a comprehensive portfolio of products and services, including BreatheSmart App, MSpirometer, and HeroTracker Sensors.
App for monitoring respiratory health and medication adherence.
Bluetooth sensor for measuring lung function metrics.
Trackers for monitoring inhaler usage and treatment compliance.
Funding Insights of CoheroHealth
CoheroHealth has successfully raised a total of $17.15M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CoheroHealth
CoheroHealth has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Aptar, StartUp Health and Samsung NEXT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund investing in early-stage tech startups
|
Locked | Locked | Locked | |
|
Early-stage centric sector-agnostic venture capital firm funding companies in the US
|
Locked | Locked | Locked | |
|
Healthcare sector investments are managed by corporate-backed Zaffre Investments.
|
Locked | Locked | Locked |
Investor details for CoheroHealth
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CoheroHealth
Investment portfolio details for CoheroHealth
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CoheroHealth
Detailed financials for CoheroHealth
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Coherohealth Comparisons
Peer comparison for CoheroHealth
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CoheroHealth
CoheroHealth operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wellth, Cureatr, Phil, Capsa Healthcare and Spencer Health Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides AI and cloud-based platform for doctors for patient engagement and care
|
|
| Locked | Locked | Locked |
Cloud-based medication management software is provided for healthcare providers.
|
|
| Locked | Locked | Locked |
Prescription drugs refill management solutions
|
|
| Locked | Locked | Locked |
Medication management systems are supplied to healthcare providers and pharmacies.
|
|
| Locked | Locked | Locked |
Devices and apps for medication adherence are provided.
|
|
| Locked | Locked | Locked |
Clinical decision support tools for respiratory diseases are provided.
|
Detailed competitors of CoheroHealth
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Coherohealth
Complete news archive for CoheroHealth
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoheroHealth
CoheroHealth was founded in 2013 and raised its 1st funding round 2 years after it was founded.
CoheroHealth is headquartered in New York, United States. It is registered at New York, New York, United States.
Joseph Condurso is the current CEO of CoheroHealth.
CoheroHealth is a funded company, having raised a total of $17.15M across 4 funding rounds to date.
CoheroHealth is a respiratory care platform that enables adults and kids with respiratory illness to actively engage in their own care. Their mobile solution incorporates an inhaler sensor and smartphone application to track real-time adherence and lung function through an engaging gamified patient interface. Cohero Health has received FDA 510(k) clearance for its mobile connected spirometer in Jun2015. The Bluetooth-connected device measures critical lung function with comparable accuracy to clinical-grade spirometers and sends the data to a smartphone or tablet. AsthmaHeroBreatheSmart. Parents and caregivers can be readily informed of medication compliance and critical patient events.
CoheroHealth's top competitors include Wellth, Phil and Capsa Healthcare.
CoheroHealth offers BreatheSmart App, MSpirometer, and HeroTracker Sensors.
CoheroHealth has 10 investors. Key investors include Aptar, StartUp Health, Samsung NEXT, OMRON Healthcare, and Three Leaf Ventures.